Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


27.08.2018

4 Aliment Pharmacol Ther
2 Dig Dis
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gut
1 Inflamm Bowel Dis
7 J Crohns Colitis
1 Mediators Inflamm
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. STAPERSMA L, van den Brink G, Szigethy EM, Escher JC, et al
    Editorial: anxiety and depression in inflammatory bowel disease - authors' reply.
    Aliment Pharmacol Ther. 2018;48:687-688.
    PubMed     Text format    

  2. LEE HH, Bae JM, Lee BI
    Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first-line therapy in inflammatory bowel disease. Authors' reply.
    Aliment Pharmacol Ther. 2018;48:684-685.
    PubMed     Text format    

  3. PARIENTE B, Blondeaux A
    Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first line therapy in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2018;48:683-684.
    PubMed     Text format    

  4. MIKOCKA-WALUS A, Knowles SR
    Editorial: anxiety and depression in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2018;48:686-687.
    PubMed     Text format    


    Dig Dis

  5. HOFFMANN P, Krisam J, Stremmel W, Gauss A, et al
    Real-World Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn's Disease at a Tertiary Referral Center.
    Dig Dis. 2018 Aug 22:1-12. doi: 10.1159/000492322.
    PubMed     Text format     Abstract available

  6. EBRAHIMI DARYANI N, Sadr M, Soltani S, Saghazadeh A, et al
    Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
    Dig Dis. 2018 Aug 22:1-12. doi: 10.1159/000492027.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  7. MICIC D, Yarur A, Gonsalves A, Rao VL, et al
    Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
    Dig Dis Sci. 2018 Aug 22. pii: 10.1007/s10620-018-5249.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  8. ZAMMIT SC, Ellul P, Girardin G, Valpiani D, et al
    Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study.
    Eur J Gastroenterol Hepatol. 2018 Aug 21. doi: 10.1097/MEG.0000000000001238.
    PubMed     Text format     Abstract available


    Gut

  9. TAN LZ, Reilly CR, Steward-Harrison LC, Balouch F, et al
    Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.
    Gut. 2018 Aug 21. pii: gutjnl-2018-316599. doi: 10.1136/gutjnl-2018-316599.
    PubMed     Text format    


    Inflamm Bowel Dis

  10. FRITZ J, Walia C, Elkadri A, Pipkorn R, et al
    A Systematic Review of Micronutrient Deficiencies in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 21. pii: 5077382. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  11. PANES J, Salas A
    Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease.
    J Crohns Colitis. 2018;12.
    PubMed     Text format     Abstract available

  12. RIVERA-NIEVES J
    Targeting leukocyte traffic: A new era for the treatment of Inflammatory bowel disease.
    J Crohns Colitis. 2018;12.
    PubMed     Text format    

  13. TRIVEDI PJ, Adams DH
    Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise.
    J Crohns Colitis. 2018;12.
    PubMed     Text format     Abstract available

  14. GUI X, Li J, Ueno A, Iacucci M, et al
    Histopathologic Features of Inflammatory Bowel Disease are Associated with Different CD4+ T Cell Subsets in Colonic Mucosal Lamina Propria.
    J Crohns Colitis. 2018 Aug 20. pii: 5076882. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. STURM A, Maaser C, Calabrese E, Annese V, et al
    ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease.
    J Crohns Colitis. 2018 Aug 23. pii: 5078200. doi: 10.1093.
    PubMed     Text format    

  16. MAASER C, Sturm A, Vavricka SR, Kucharzik T, et al
    ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease.
    J Crohns Colitis. 2018 Aug 23. pii: 5078195. doi: 10.1093.
    PubMed     Text format    

  17. TAMAN H, Fenton CG, Hensel IV, Anderssen E, et al
    Genome-Wide DNA Methylation in Treatment-Naive Ulcerative Colitis.
    J Crohns Colitis. 2018 Aug 22. pii: 5077493. doi: 10.1093.
    PubMed     Text format     Abstract available


    Mediators Inflamm

  18. BOROS E, Kellermayer Z, Balogh P, Strifler G, et al
    Elevated Expression of AXL May Contribute to the Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease Patients.
    Mediators Inflamm. 2018;2018:3241406.
    PubMed     Text format     Abstract available


    PLoS One

  19. ARGENY S, Tamandl D, Scharitzer M, Stift A, et al
    Visceral fat area measured with computed tomography does not predict postoperative course in Crohn s disease patients.
    PLoS One. 2018;13:e0202220.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: